Company intelligence / Profile preview

Eye Centers of Racine & Kenosha

Racine, Wisconsin, United States

Ownership: Private
Employees: ~27
Development stage: Other

Overview

Eye Centers of Racine & Kenosha is a leading ophthalmology group providing both surgical and non-surgical clinical care and vision correction interventions. It is frequently first to introduce innovative technologies in Wisconsin, such as MIGS stents for glaucoma and advanced laser vision correction (e.g., SMILE, LASIK, PRK) and laser vitreolysis for eye floaters. They pioneer early adoption and clinical deployment of new ophthalmic devices and procedures, but do not appear to run interventional pharma pipelines or clinical drug trials[1][3][6].

Therapeutic areas: Ophthalmology
Modalities: DeviceBiologicSmall moleculeSurgical procedureLaser procedure
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Eye Centers of Racine & Kenosha.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eye Centers of Racine & Kenosha.

Explore the full profile